Statin suppresses sirtuin 6 through miR-495, increasing FoxO1-dependent hepatic gluconeogenesis
Conclusion: Statin induces miR-495 to suppress Sirt6 expression, which leads to enhancement of FoxO1-mediated hepatic gluconeogenesis. Thus, Sirt6 activation may offer a promising strategy for preventing statin-induced hyperglycemia.
Source: Theranostics - Category: Molecular Biology Authors: Min Yan Shi, In Hyuk Bang, Chang Yeob Han, Dae Ho Lee, Byung-Hyun Park, Eun Ju Bae Tags: Research Paper Source Type: research
More News: Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Genetics | Liver | Molecular Biology | Statin Therapy | Urology & Nephrology